{
  "meta": {
    "timestamp": "2025-01-06T12:59:52.401220",
    "version": "1.0",
    "type": "search_analysis"
  },
  "companies": [
    {
      "company_name": "Progyny Inc",
      "symbol": "PGNY",
      "analysis": {
        "historical": {
          "risk_score": 65,
          "key_risks": [
            "Regulatory and compliance challenges related to HIPAA, ERISA, PPACA, and MHPAEA",
            "Loss of a major client representing 12-13% of revenue",
            "Legal investigations for potential securities law violations and breaches of fiduciary duties",
            "Market competition and growth hurdles in the fertility benefits space"
          ],
          "controversies": [
            "Allegations of fraudulent practices, including treatment authorization denials",
            "Investigation by multiple law firms for securities law violations"
          ],
          "environmental_issues": [],
          "social_issues": [
            "Ethical concerns over business practices",
            "Impact of reproductive rights debates on operations and public perception"
          ],
          "governance_issues": [
            "Breaches of fiduciary duties by officers and directors",
            "Legal investigations into governance practices"
          ],
          "recommendation": "caution",
          "confidence_score": 80
        },
        "evidence": {
          "sources": [
            {
              "url": "",
              "title": "4 Compliance Considerations for Benefits Leaders in 2024 - Progyny",
              "snippet": "The foundational considerations for compliance in fertility and family building benefits include a combination of general healthcare regulation issues, HIPAA, ERISA, and specific mandates, PPACA and MHPAEA. This blog breaks down these regulatory issues to help you understand how they fit into your overall compliance and communication strategies.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Progyny Inc Progyny Inc regulatory challenges fertility benefits",
              "retrieved_at": "2025-01-06T19:59:27.472126+00:00",
              "published_date": null,
              "source_hash": "74960e71534051cd5cf995e70deab725"
            },
            {
              "url": "",
              "title": "Progyny's SWOT analysis: fertility benefits leader faces utilization ...",
              "snippet": "Progyny, Inc. (NASDAQ:PGNY), a leading provider of fertility and family building benefits solutions with annual revenue exceeding $1.1 billion, finds itself at a crossroads as it navigates a ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Progyny Inc Progyny Inc regulatory challenges fertility benefits",
              "retrieved_at": "2025-01-06T19:59:27.472239+00:00",
              "published_date": null,
              "source_hash": "374aaae3428598e187e9468de85a1975"
            },
            {
              "url": "",
              "title": "Progyny's SWOT analysis: fertility benefits firm faces growth hurdles ...",
              "snippet": "Progyny, Inc. (NASDAQ: PGNY), a leading provider of fertility and family-building benefits solutions, finds itself at a critical juncture as it navigates a landscape of both promising opportunities and significant challenges.The company's recent financial performance and strategic initiatives have drawn mixed reactions from analysts and investors, highlighting the complex dynamics at play in ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Progyny Inc Progyny Inc regulatory challenges fertility benefits",
              "retrieved_at": "2025-01-06T19:59:27.472255+00:00",
              "published_date": null,
              "source_hash": "745a218b396d6bd018ceb13df6aa6128"
            },
            {
              "url": "",
              "title": "Progyny's SWOT analysis: fertility benefits leader faces utilization ...",
              "snippet": "Progyny, Inc. (NASDAQ: PGNY), a leading provider of fertility and family building benefits solutions with annual revenue exceeding $1.1 billion, finds itself at a crossroads as it navigates a complex landscape of growth opportunities and operational challenges.According to InvestingPro analysis, the company appears undervalued despite maintaining a GREAT financial health score of 3.39 out of 5 ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Progyny Inc Progyny Inc regulatory challenges fertility benefits",
              "retrieved_at": "2025-01-06T19:59:27.472266+00:00",
              "published_date": null,
              "source_hash": "a4ca8143b6a06e46244026186d504217"
            },
            {
              "url": "",
              "title": "Progyny's Challenges and Insights into Fertility Benefits Landscape ...",
              "snippet": "Progyny's Position in the Fertility Benefits Market. Progyny Inc (NASDAQ: PGNY) is making strides as a leader in fertility and family building benefits solutions within the United States. Recently, KeyBanc Capital Markets upheld a Sector Weight rating on the company, reflecting prudent attention towards the evolving competitive landscape.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Progyny Inc Progyny Inc regulatory challenges fertility benefits",
              "retrieved_at": "2025-01-06T19:59:27.472276+00:00",
              "published_date": null,
              "source_hash": "89ae8fab9c3a5621c98d59eb80bbc357"
            },
            {
              "url": "",
              "title": "Progyny's Journey: Growth Challenges and Future Prospects",
              "snippet": "Progyny Inc. (NASDAQ: PGNY) stands at a pivotal point in its journey as a leading provider of innovative fertility and family building benefits solutions. Established as a pioneer in the fertility benefits sector after going public in 2019, the company has been instrumental in harnessing technology to cater to an expanding clientele of self ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Progyny Inc Progyny Inc regulatory challenges fertility benefits",
              "retrieved_at": "2025-01-06T19:59:27.472285+00:00",
              "published_date": null,
              "source_hash": "4abbf14e5e93a95c927c61d95f71e267"
            },
            {
              "url": "",
              "title": "Compliance and communication best practices for fertility and ... - Progyny",
              "snippet": "1/3 of fertility issues are male factor ; Black women are 2x likely to be diagnosed with fertility issues, but less likely to seek medical help compared to white women ; 2/3 of LGBTQ+ individuals report needing reproductive technology, surrogacy, or adoption support ; 68% of adults would switch jobs for better family building benefits",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Progyny Inc Progyny Inc regulatory challenges fertility benefits",
              "retrieved_at": "2025-01-06T19:59:27.472295+00:00",
              "published_date": null,
              "source_hash": "7f071675b3c9d7fa89c1ff7e2a0a2d59"
            },
            {
              "url": "",
              "title": "Fertility-benefits provider Progyny's stock on track for ... - MSN",
              "snippet": "Progyny Inc.'s stock tumbled 31% Thursday, to put it on track for its biggest-ever one-day decline, after the provider of fertility-care benefits for employers said a \"significant\" client ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Progyny Inc Progyny Inc regulatory challenges fertility benefits",
              "retrieved_at": "2025-01-06T19:59:27.472304+00:00",
              "published_date": null,
              "source_hash": "4796ce1de04cfd10ad02f3da80666f39"
            },
            {
              "url": "",
              "title": "Fertility-benefits provider Progyny's stock on track for biggest-ever ...",
              "snippet": "Progyny Inc.'s stock tumbled 31% Thursday, to put it on track for its biggest-ever one-day decline, after the provider of fertility-care benefits for employers said a \"significant\" client had ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Progyny Inc Progyny Inc regulatory challenges fertility benefits",
              "retrieved_at": "2025-01-06T19:59:27.472312+00:00",
              "published_date": null,
              "source_hash": "1e9c163e830c29c3a99b5b95431d6920"
            },
            {
              "url": "",
              "title": "Progyny is First Fertility Benefits Solution to Publish Outcomes with ...",
              "snippet": "NEW YORK, July 27, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Progyny Inc Progyny Inc regulatory challenges fertility benefits",
              "retrieved_at": "2025-01-06T19:59:27.472321+00:00",
              "published_date": null,
              "source_hash": "1eab5488224bbc079c82f18ec0077bf2"
            },
            {
              "url": "",
              "title": "Progyny's SWOT analysis: fertility benefits leader faces utilization challenges",
              "snippet": "Progyny, Inc. (NASDAQ:PGNY), a leading provider of fertility and family building benefits solutions with ... of growth opportunities and operational challenges. According to InvestingPro analysis ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Progyny Inc Progyny Inc regulatory challenges fertility benefits",
              "retrieved_at": "2025-01-06T19:59:29.920562+00:00",
              "published_date": "2024-12-15T10:27:00+00:00",
              "source_hash": "e4fd68d3eae40764b0c70267799d7fc3"
            },
            {
              "url": "",
              "title": "Progyny Stock Saw Big Buys From the CEO and a Former CEO",
              "snippet": "CEO Peter Anevski and Executive Chairman David Schlanger bought a total of $5.2 million of stock of fertility-benefits firm Progyny.",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Progyny Inc Progyny Inc regulatory challenges fertility benefits",
              "retrieved_at": "2025-01-06T19:59:29.920667+00:00",
              "published_date": "2025-01-03T08:00:00+00:00",
              "source_hash": "5667b77975b24e3ff5e55f632c4216a0"
            },
            {
              "url": "",
              "title": "Progyny, Inc. (PGNY)",
              "snippet": "NEW YORK, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits ... the unique challenges LGBTQ+ patients ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Progyny Inc Progyny Inc regulatory challenges fertility benefits",
              "retrieved_at": "2025-01-06T19:59:29.920694+00:00",
              "published_date": "2024-12-30T23:33:00+00:00",
              "source_hash": "bef948f76180d5b4ca31342d46337288"
            },
            {
              "url": "",
              "title": "Progyny Faces Challenges with Lowered Expectations Amid New Initiatives",
              "snippet": "Despite these challenges, there are positive ... Begin your TipRanks Premium journey today. Progyny (PGNY) Company Description: Progyny, Inc. is a medical device company, which engages in the ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Progyny Inc Progyny Inc regulatory challenges fertility benefits",
              "retrieved_at": "2025-01-06T19:59:29.920718+00:00",
              "published_date": "2024-11-14T01:37:00+00:00",
              "source_hash": "7a50d1c85ba618d28d246d8839490f2f"
            },
            {
              "url": "",
              "title": "Progyny Chief Executive Officer Trades $3.03M In Company Stock",
              "snippet": "It was revealed in a recent SEC filing that Peter Anevski, Chief Executive Officer at Progyny PGNY +13.3% Get Free Report made a noteworthy insider purchase on December 26,.",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Progyny Inc Progyny Inc lawsuits or legal disputes",
              "retrieved_at": "2025-01-06T19:59:38.008967+00:00",
              "published_date": "2024-12-27T14:02:00+00:00",
              "source_hash": "7d95010e14ecb6f1e8f5ae0324cbf2c7"
            },
            {
              "url": "",
              "title": "Progyny, Inc. (PGNY) Investigation | Hagens Berman",
              "snippet": "Progyny, a benefits management company that specializes in fertility and family building benefits solutions, informed investors that the Client it is scheduled to lose represents approximately 670,000 members as of June 30, 2024 and comprised 12% and 13% of the Company's revenue for the six months ended June 30, 2024 and the twelve months ended December 31, 2023.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Progyny Inc Progyny Inc lawsuits or legal disputes",
              "retrieved_at": "2025-01-06T19:59:35.360180+00:00",
              "published_date": null,
              "source_hash": "5393dece005436351f9cd29e36b88507"
            },
            {
              "url": "",
              "title": "Progyny, Inc. | BBB Complaints | Better Business Bureau",
              "snippet": "their business ethics are fraudulent. My Progyny ID for reference is *********. I have uploaded the treatment authorization date (should have stayed open for 60 days) and the e-mail chain denying ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Progyny Inc Progyny Inc ethical concerns reproductive technologies",
              "retrieved_at": "2025-01-06T19:59:31.562291+00:00",
              "published_date": null,
              "source_hash": "0cd9646fd1d08647ddee42d041c883cf"
            },
            {
              "url": "",
              "title": "Progyny Inc (PGNY) Under Investigation by Robbins LLP for Potent",
              "snippet": "On December 11, 2024, Robbins LLP, a law firm specializing in shareholder rights, announced an investigation into Progyny Inc (PGNY, Financial) to determine if certain officers and directors of the company violated securities laws and breached fiduciary duties to shareholders.Progyny Inc is a benefits management company that provides fertility and family building benefits solutions to ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Progyny Inc Progyny Inc lawsuits or legal disputes",
              "retrieved_at": "2025-01-06T19:59:35.360288+00:00",
              "published_date": null,
              "source_hash": "ec8aa94b5f017b7f741ea9ac09094cc7"
            },
            {
              "url": "",
              "title": "Progyny, Inc. - Spruce Point Capital Management LLC",
              "snippet": "After conducting a forensic financial and accounting review, Spruce Point believes Progyny, Inc. (NYSE: PGNY), a market capitalization fertility benefit manager, possesses a broader range of financial, operating, business model, and management issues that go far beyond those previously discussed and raise serious questions about management's disclosures and marketing claims and the ethics of ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Progyny Inc Progyny Inc ethical concerns reproductive technologies",
              "retrieved_at": "2025-01-06T19:59:31.562319+00:00",
              "published_date": null,
              "source_hash": "ac04e4cf78fbdbc77223b00b67063d8d"
            },
            {
              "url": "",
              "title": "Progyny, Inc. Investigation - Robbins LLP",
              "snippet": "Robbins LLP is investigating Progyny, Inc. (NASDAQ: PGNY) to determine whether certain Progyny officers and directors violated securities laws and breached fiduciary duties to shareholders. Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Progyny Inc Progyny Inc lawsuits or legal disputes",
              "retrieved_at": "2025-01-06T19:59:35.360307+00:00",
              "published_date": null,
              "source_hash": "55e1d0970d0ce35e12dd5917c90c3f3f"
            },
            {
              "url": "",
              "title": "PGNY Stockholders: Robbins LLP is Investigating the Officers and ...",
              "snippet": "SAN DIEGO, Dec. 18, 2024 /PRNewswire/ -- Shareholder rights law firm Robbins LLP is investigating Progyny, Inc. (NASDAQ: PGNY) to determine whether certain Progyny officers and directors violated ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Progyny Inc Progyny Inc lawsuits or legal disputes",
              "retrieved_at": "2025-01-06T19:59:35.360361+00:00",
              "published_date": null,
              "source_hash": "41099096cef8e74e3cc529390363125f"
            },
            {
              "url": "",
              "title": "Investigation into Progyny's Leadership: Shareholders Speak Out",
              "snippet": "Understanding the Investigation of Progyny, Inc. Robbins LLP, a prominent law firm specializing in shareholder rights, has initiated an investigation concerning Progyny, Inc. This company is a leader in benefits management, particularly focusing on fertility and family building solutions for various employers.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Progyny Inc Progyny Inc ethical concerns reproductive technologies",
              "retrieved_at": "2025-01-06T19:59:31.562349+00:00",
              "published_date": null,
              "source_hash": "d4cd91b4d5fda1553905c8165bf7f794"
            },
            {
              "url": "",
              "title": "Investigating Investor Claims Against Progyny: Impact Analysis",
              "snippet": "Background of Progyny, Inc. Progyny is known for providing fertility benefits and services in the healthcare sector. The company aims to improve fertility treatment accessibility and effectiveness. However, recent events have raised concerns about its client relationships and overall business practices, leading to an inquiry by legal experts at ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Progyny Inc Progyny Inc ethical concerns reproductive technologies",
              "retrieved_at": "2025-01-06T19:59:31.562359+00:00",
              "published_date": null,
              "source_hash": "f505664a9135d207f6aee5ee73548610"
            },
            {
              "url": "",
              "title": "PGNY Stockholders: Robbins LLP is Investigating the Officers and ...",
              "snippet": "SAN DIEGO, Dec. 18, 2024 /PRNewswire/ -- Shareholder rights law firm Robbins LLP is investigating Progyny, Inc. (NASDAQ: PGNY) to determine whether certain Progyny officers and directors violated securities laws and breached fiduciary duties to shareholders. Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Progyny Inc Progyny Inc lawsuits or legal disputes",
              "retrieved_at": "2025-01-06T19:59:35.360372+00:00",
              "published_date": null,
              "source_hash": "d0f35d0c8f5215c42d29fbd4eb2b48ea"
            },
            {
              "url": "",
              "title": "Progyny (PGNY) Client Retention Narrative Under Examination - GlobeNewswire",
              "snippet": "SAN FRANCISCO, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Fertility benefits provider Progyny, Inc. (NASDAQ: PGNY) is under intense scrutiny following the... October 21, 2024 20:12 ET | Source: Hagens ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Progyny Inc Progyny Inc ethical concerns reproductive technologies",
              "retrieved_at": "2025-01-06T19:59:31.562380+00:00",
              "published_date": null,
              "source_hash": "528b626ba674fff9b33fa53e10c50efc"
            },
            {
              "url": "",
              "title": "Progyny slips amid concerns over Alabama fertility ruling",
              "snippet": "Fertility benefits provider Progyny (NASDAQ:PGNY ... the effects of which could soon extend across the U.S., according to reproductive rights advocates. \"This cruel ruling, and the subsequent ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Progyny Inc Progyny Inc ethical concerns reproductive technologies",
              "retrieved_at": "2025-01-06T19:59:33.836756+00:00",
              "published_date": "2024-02-22T18:43:00+00:00",
              "source_hash": "7ef7d411c43153dd597d1b6900a53e30"
            },
            {
              "url": "",
              "title": "Progyny (NASDAQ:PGNY) Shares Gap Up Following Insider Buying Activity",
              "snippet": "Progyny, Inc. (NASDAQ:PGNY - Get Free Report) shares gapped up prior to trading on Friday following insider buying activity. The stock had previously closed at $14.71, but opened at $15.81. Progyny shares last traded at $16.",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Progyny Inc Progyny Inc ethical concerns reproductive technologies",
              "retrieved_at": "2025-01-06T19:59:33.836831+00:00",
              "published_date": "2024-12-29T05:06:00+00:00",
              "source_hash": "7e979b2886f4dbf0207d417d25882318"
            },
            {
              "url": "",
              "title": "Barclays Issues a Buy Rating on Progyny (PGNY)",
              "snippet": "Progyny (PGNY) Company Description: Progyny, Inc. is a medical device company, which engages in the field of reproductive medicine, translating scientific discoveries related to early embryo ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Progyny Inc Progyny Inc ethical concerns reproductive technologies",
              "retrieved_at": "2025-01-06T19:59:33.836862+00:00",
              "published_date": "2024-11-13T04:11:00+00:00",
              "source_hash": "8ee5d42319a32d9b93819b229a11e3f4"
            },
            {
              "url": "",
              "title": "Kuehn Law Encourages Investors of Progyny, Inc. to Contact Law Firm",
              "snippet": "December 28, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Progyny, Inc. (NASDAQ: PGNY) breached their fiduciary duties to shareholders.",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Progyny Inc Progyny Inc lawsuits or legal disputes",
              "retrieved_at": "2025-01-06T19:59:38.008938+00:00",
              "published_date": "2024-12-28T18:27:00+00:00",
              "source_hash": "9c1caa6d1401b9467814205ee10f807b"
            },
            {
              "url": "",
              "title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of ...",
              "snippet": "NEW YORK, Feb. 7, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Progyny, Inc. (\"Progyny\" or the \"Company\") (NASDAQ: PGNY).Such investors are advised to ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Progyny Inc Progyny Inc lawsuits or legal disputes",
              "retrieved_at": "2025-01-06T19:59:35.360321+00:00",
              "published_date": null,
              "source_hash": "2614f010f79a357bee4c97dc846e0b09"
            },
            {
              "url": "",
              "title": "Bragar Eagel & Squire, P.C. | Progyny, Inc. - bespc.com",
              "snippet": "The individual or institution below (\"Plaintiff\") has reviewed and agrees to the Bragar Eagel & Squire, P.C. (\"BESPC\") retainer agreement and authorizes BESPC to prosecute an action on Plaintiff's behalf under the federal securities laws or applicable state laws to recover damages on behalf of investors in Progyny. BESPC will prosecute the action on a full contingency basis and will ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Progyny Inc Progyny Inc lawsuits or legal disputes",
              "retrieved_at": "2025-01-06T19:59:35.360334+00:00",
              "published_date": null,
              "source_hash": "db1e47e5b2a019789160a852fb24247e"
            },
            {
              "url": "",
              "title": "Progyny, Inc. - Johnson Fistel",
              "snippet": "Or for more information, contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471.. There is no cost or obligation to you. What is Johnson Fistel Investigating? On September 18, 2024, Progyny revealed in a filing with the U.S. Securities and Exchange Commission that a major client had opted to exercise a 90-day termination option for its services agreement, effective January 1, 2025.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Progyny Inc Progyny Inc lawsuits or legal disputes",
              "retrieved_at": "2025-01-06T19:59:35.360349+00:00",
              "published_date": null,
              "source_hash": "760a794e0e63bd7a92d96d2da08f29c2"
            },
            {
              "url": "",
              "title": "PROGYNY ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire",
              "snippet": "If you purchased or otherwise acquired Progyny shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Progyny Inc Progyny Inc lawsuits or legal disputes",
              "retrieved_at": "2025-01-06T19:59:35.360384+00:00",
              "published_date": null,
              "source_hash": "20e100f547f6919b257eeba9436ce813"
            },
            {
              "url": "",
              "title": "Progyny, Inc. - The Rosen Law",
              "snippet": "Company Name: Progyny, Inc. Stock Symbol: PGNY. Class Period: N/A. Court: N/A. Share This Class Action. Join This Class Action. Why Rosen Law. The Rosen Law Firm has been ranked among the top 4 law firms each year since 2013 for the number of successful securities class actions on behalf of investors. In 2019 alone, our firm recovered $438 ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Progyny Inc Progyny Inc lawsuits or legal disputes",
              "retrieved_at": "2025-01-06T19:59:35.360396+00:00",
              "published_date": null,
              "source_hash": "da0b58899e381693632e927afa669d6d"
            },
            {
              "url": "",
              "title": "Johnson Fistel has Commenced an Investigation on Behalf of Progyny (PGNY) Shareholders",
              "snippet": "SAN DIEGO, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Progyny, Inc. (NASDAQ ... class action lawsuits. For more information about ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Progyny Inc Progyny Inc lawsuits or legal disputes",
              "retrieved_at": "2025-01-06T19:59:38.008844+00:00",
              "published_date": "2024-11-18T16:25:00+00:00",
              "source_hash": "eff4e687f7411ab2c80ac278f357519b"
            },
            {
              "url": "",
              "title": "Bullish Move: David Schlanger Shows Confidence, Acquires $2.20M In Progyny Stock",
              "snippet": "What Happened: Schlanger made a significant move by purchasing 150,000 shares of Progyny as reported in a Form 4 filing with the U.S. Securities and Exchange Commission. The transaction's total worth stands at $2,202,330.",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Progyny Inc Progyny Inc lawsuits or legal disputes",
              "retrieved_at": "2025-01-06T19:59:38.008991+00:00",
              "published_date": "2024-12-27T14:02:00+00:00",
              "source_hash": "12a53b33a88ab0d90fd311194cdfddaf"
            },
            {
              "url": "",
              "title": "Progyny stock plunges 18% amid lowered guidance, Truist downgrade",
              "snippet": "Progyny also lowered its 2024 guidance, stating that it now sees reporting adjusted EPS of $1.54 to $1.57 on revenue of $1.135B to $1.15B. Analysts, on average, had been expected adjusted EPS of ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Progyny Inc Progyny Inc lawsuits or legal disputes",
              "retrieved_at": "2025-01-06T19:59:38.009013+00:00",
              "published_date": "2024-11-20T11:36:00+00:00",
              "source_hash": "9538cb7af0cd8e8d0b5d259ad4d3fa8f"
            }
          ],
          "queries": [
            {
              "category": "financial_legal",
              "query": "Progyny Inc regulatory challenges fertility benefits",
              "rationale": "Investigate potential legal and regulatory hurdles affecting Progyny's operations in the fertility benefits sector",
              "priority": 1
            },
            {
              "category": "ethical_social",
              "query": "Progyny Inc ethical concerns reproductive technologies",
              "rationale": "Explore ethical issues related to the use of advanced reproductive technologies and genetic material handling by Progyny",
              "priority": 2
            },
            {
              "category": "financial_legal",
              "query": "Progyny Inc lawsuits or legal disputes",
              "rationale": "Identify any ongoing or past legal disputes involving Progyny that could impact its financial stability or reputation",
              "priority": 3
            }
          ]
        },
        "categorization": {
          "product_issues": [],
          "conduct_issues": [],
          "tags": [],
          "patterns": {}
        }
      },
      "metadata": {
        "analysis_timestamp": "2025-01-06T12:59:52.401227",
        "data_confidence": 80,
        "pattern_confidence": null
      }
    }
  ]
}